Viridian Therapeutics, Inc.\DE — All Filings
773 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002586 | Mar 27, 2026 | — |
| 4/A | 4/A | 0001193125-26-099023 | Mar 9, 2026 | Mar 3, 2026 |
| 4/A | 4/A | 0001193125-26-099014 | Mar 9, 2026 | Mar 3, 2026 |
| 4/A | 4/A | 0001193125-26-099008 | Mar 9, 2026 | Mar 3, 2026 |
| 4/A | 4/A | 0001193125-26-099007 | Mar 9, 2026 | Mar 3, 2026 |
| 4 | 4 | 0001193125-26-092074 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-092071 | Mar 4, 2026 | Mar 2, 2026 |
| 4/A | 4/A | 0001193125-26-092068 | Mar 4, 2026 | Mar 3, 2025 |
| 4/A | 4/A | 0001193125-26-092065 | Mar 4, 2026 | Mar 3, 2025 |
| 4 | 4 | 0001193125-26-092040 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-092036 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-092028 | Mar 4, 2026 | Mar 2, 2026 |
| 144 | — | 0001959173-26-001932 | Mar 4, 2026 | — |
| 144 | — | 0001959173-26-001929 | Mar 4, 2026 | — |
| 144 | — | 0001959173-26-001925 | Mar 4, 2026 | — |
| 144 | — | 0001959173-26-001921 | Mar 4, 2026 | — |
| S-8 | S-8 | 0001193125-26-076844 | Feb 26, 2026 | — |
| 10-K | 10-K | 0001590750-26-000007 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-073391 | Feb 26, 2026 | — |
| SCHEDULE 13G/A | — | 0001907884-26-000004 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001172661-26-000723 | Feb 13, 2026 | — |
| 4 | 4 | 0001193125-26-001097 | Jan 2, 2026 | Dec 31, 2025 |
| 144 | — | 0001959173-25-007945 | Dec 31, 2025 | — |
| SCHEDULE 13G/A | — | 0001831942-25-000032 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001590750-25-000020 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-265711 | Nov 5, 2025 | — |
| SCHEDULE 13D/A | — | 0001104659-25-102608 | Oct 27, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-102606 | Oct 27, 2025 | Oct 23, 2025 |
| 8-K | 8-K | 0001193125-25-247410 | Oct 23, 2025 | Oct 21, 2025 |
| 424B5 | 424B5 | 0001193125-25-247409 | Oct 23, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-245209 | Oct 21, 2025 | — |
| 8-K | 8-K | 0001193125-25-245206 | Oct 21, 2025 | — |
| 8-K | 8-K | 0001193125-25-243039 | Oct 20, 2025 | Oct 17, 2025 |
| S-3ASR | S-3ASR | 0001193125-25-196564 | Sep 5, 2025 | — |
| S-8 | S-8 | 0001193125-25-174447 | Aug 6, 2025 | — |
| 10-Q | 10-Q | 0001590750-25-000012 | Aug 6, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001193125-25-173983 | Aug 6, 2025 | — |
| 8-K | 8-K | 0001193125-25-168614 | Jul 30, 2025 | — |
| 4 | 4 | 0000950170-25-093118 | Jul 2, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093111 | Jul 2, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093107 | Jul 2, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093102 | Jul 2, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093099 | Jul 2, 2025 | Jul 1, 2025 |
| 4 | 4 | 0000950170-25-093098 | Jul 2, 2025 | Jul 1, 2025 |
| 8-K | 8-K | 0001193125-25-145741 | Jun 24, 2025 | Jun 20, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-058580 | Jun 11, 2025 | Jun 9, 2025 |
| 8-K | 8-K | 0001193125-25-122821 | May 20, 2025 | — |
| SCHEDULE 13G | — | 0001085146-25-003251 | May 15, 2025 | — |
| 10-Q | 10-Q | 0001590750-25-000008 | May 6, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001193125-25-113291 | May 6, 2025 | — |